Send to

Choose Destination
See comment in PubMed Commons below
Naturwissenschaften. 1998 Mar;85(3):109-16.

Societal and commercial issues affecting the future of biotechnology in the United States: a survey of researchers' perceptions.

Author information

  • 1Department of Biological and Health Sciences, Empire State College, State University of New York, NY 10014-4382, USA.


A 1995 survey of 1,257 U.S. recombinant DNA researchers assessed how they view outside factors affecting their work, including public and media attention; regulation; funding; international competition; commercialization of research and university/ industry collaboration; health care reform efforts; and patenting laws and policies. Generally, respondents view public attention as-having had positive effects on biotechnology progress, but they are concerned about the decrease in R&D funding, especially from government; the loss of scientific openness and basic-research quality caused by academic/industrial collaboration; international competition, particularly from Japan and Germany; overly stringent regulations that control R&D processes rather than products; inefficient regulatory agencies focused on irrelevant criteria; and threats to basic biomedical research from the short-term cost focus of managed-care companies.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk